Skip to main content
. 2016 Jan 20;129(2):142–146. doi: 10.4103/0366-6999.173438

Table 1.

Clinical features of the 45 patients with late-onset MADD

Clinical features Numbers of patients
Gender
 Male 27/45 (60.0)
Median age (years), range 28 (6, 44)
Median onset ages (years), range 21 (4, 44)
Muscle weakness
 Proximal limbs 45/45 (100)
 Distal limbs 0/45 (0)
 Neck 45/45 (100)
 Mastication 21/45 (46.7)
Exercise intolerance 45/45 (100)
Myalgia 21/45 (46.7)
Muscle atrophy 10/45 (22.2)
Gastrointestinal symptoms 26/45 (57.8)
Electromyography
 Myopathic changes 28/42 (66.7)
 Neurogenic changes 2/42 (4.8)
 No obvious abnormality 12/42 (28.6)
Fatty liver 6/31 (19.4)
 CK (U/L), mean (range) 888 (168, 2526)
 LDH (U/L), mean (range) 962 (253, 3507)
 AST (U/L), mean (range) 139 (37, 447)

Values are presented as n/N (%). MADD: Multiple acyl-coenzyme A dehydrogenase deficiency; CK: Creatinine kinase; AST: Aspartate aminotransferase; LDH: Lactate dehydrogenase. Upper limit of normal: CK 140 U/L, LDH 245 U/L, and AST 40 U/L.